Clinical and Functional State of the Intestine in Patients with Psoriatic Arthritis
https://doi.org/10.31146/1682-8658-ecg-246-2-17-22
Abstract
The aim of the study was to analyze clinical symptoms, endoscopic and histological changes in the colonic mucosa of patients with psoriatic arthritis. Materials and methods. 36 patients with psoriatic arthritis were examined, of whom 52.7% were women and 47.2% were men, with a mean age of 43.6±11.7 years. All patients underwent standard clinical, laboratory and instrumental examinations, ultrasound, and radiography of the hands, feet, and pelvis. Microbiological testing was conducted to detect intestinal dysbiosis, and colonoscopy with intestinal mucosal biopsy was performed. Results. Colonoscopy revealed pathological changes in 66.6% of cases. In 88.8% of cases, pathological changes in the intestines were detected only through histomorphological examination, which highlights the importance of this method in diagnosis and implementation of targeted appropriate therapy for gastrointestinal tract involvement in patients with psoriatic arthritis.
About the Authors
Kh. T. Mirahmedova
Tashkent Medical Academy
Russian Federation
Russian Federation
M. T. Rustamova
Tashkent Medical Academy
Russian Federation
Russian Federation
Kh. H. Khamraev
Samarkand State Medical University
Russian Federation
Russian Federation
References
1. Chia A.Y.T., Ang G.W.X., Chan A.S.Y., Chan W., Chong T.K.Y., Leung Y.Y. Managing Psoriatic Arthritis With Inflammatory Bowel Disease and/or Uveitis. Front Med (Lausanne). 2021 Sep 16;8:737256. doi: 10.3389/fmed.2021.737256.
2. Agababova E.R. Spondyloarthritis as an object of promising scientific research in rheumatology. Selected lectures on clinical rheumatology. Moscow: Medicine. 2005. 182 p. (in Russ.)@@ Агабабова Э.Р. Спондилоартриты как объект перспективных научных исследований в ревматологии. Избранные лекции по клинической ревматологии. - М.: Медицина. 2005. -182с.
3. O’Neill C.A., Monteleone G., McLaughlin J.T, Paus R. The gut-skin axis in health and disease: a paradigm with therapeutic implications. Bioessays. 2016;38(11):1167-1176.
4. Coates L.C., Corp N., van der Windt D.A., Soriano E.R., Kavanaugh A. GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting. J Rheumatol Suppl. 2021 Jun;97:65-66. doi: 10.3899/jrheum.201681.
5. Damiani G., Bragazzi N., Karimkhani Aksut C. et al. The global, regional, and national burden of psoriasis: results and insights from the Global Burden of Disease 2019 Study. Front Med (Lausanne). 2021; 8:743180.
6. Badokin V.V. Tumor necrosis factor-alpha is the main target of pathogenetic therapy of psoriasis and psoriatic arthritis. Consilium Medicum. 2006;(1):24-29. (in Russ.)@@ Бадокин В.В. Фактор некроза опухоли -альфа - основная мишень патогенетической терапии псориаза и псориатического артрита. Consilium Medicum. -2006. - № 1. - С.24-29.
7. Voronenko V.A., Gulyaev S.V. Chronic inflammatory bowel lesions and seronegative spondyloarthritis. Scientific and practical rheumatology. 2003;(5):67-69. (in Russ.)@@ Вороненко В.А., Гуляев С.В. Хронические воспалительные поражения кишечника и серонегативные спондилоартриты. Научно-практическая ревматология. -2003. - № 5. -С.67-69.
8. Gulneva M. Yu., Noskov S.M., Malifeeva E.V., Shevchenko E.N.Intestinal microbiocenosis in rheumatoid arthritis in the elderly. Clinical Gerontology. 2011;(3-4):8-12. (in Russ.)@@ Гульнева М.Ю., Носков С.М., Малифеева Э.В., Шевченко Е.Н. Микробиоценоз кишечника при ревматоидном артрите в пожилом возрасте. Клиническая геронтология. -2011.-№ 3-4.-С.8-12.
9. Attauabi M., Wewer M.D., Bendtsen F., Seidelin J.B., Burisch J. Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis. Inflamm Bowel Dis. 2022 Nov 2;28(11):1756-1765. doi: 10.1093/ibd/izac003.
10. Korsakova Yu.L. Psoriasis and psoriatic arthritis: current issues. Sovrem. rheumatology. 2012;(3):28-32. (in Russ.)@@ Корсакова Ю.Л. Псориаз и псориатический артрит: актуальные вопросы. Соврем. ревматол. - 2012. - № 3. - С. 28-32.
11. Kunder E.V. Psoriatic arthritis: classification, activity, laboratory and instrumental diagnostics. Vestn. VGM. 2013;12(2):31-41. (in Russ.)@@ Кундер Е.В. Псориатический артрит: классификация, активность, лабораторная и инструментальная диагностика. Вестн. ВГМ. - 2013. - Т. 12, № 2. - С. 31-41.
12. Fu Y., Lee C.H., Chi C.C. Association of Psoriasis With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. JAMA Dermatol. 2018 Dec 1;154(12):1417-1423. doi: 10.1001/jamadermatol.2018.3631.
13. Freuer D., Linseisen J., Meisinger C. Association Between Inflammatory Bowel Disease and Both Psoriasis and Psoriatic Arthritis: A Bidirectional 2-Sample Mendelian Randomization Study. JAMA Dermatol. 2022 Sep 14;158(11):1262-8. doi: 10.1001/jamadermatol.2022.3682.
14. Korotaeva T.V. Psoriatic arthritis: pathogenetic rationale for modern therapeutic approaches. Doctor.Ru. 2021; 20(7): 19-25. (in Russ.)@@ Коротаева Т.В. Псориатический артрит: патогенетическое обоснование современных терапевтических подходов. Доктор.Ру. 2021; 20(7): 19-25.
15. Myers B., Brownstone N., Reddy V. et al. The gut microbiome in psoriasis and psoriatic arthritis. Best Pract Res Clin Rheumatol. 2019 Dec;33(6):101494. doi: 10.1016/j.berh.2020.101494.
16. Gossec L., Smolen J.S., Gaujoux-Viala C. et al, Emery P; European League Against Rheumatism. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis. 2012 Jan;71(1):4-12. doi: 10.1136/annrheumdis-2011-200350.
17. Yeys E.M., Mielants H. Symposium: Rheumatological manifestation of the enteropaties. Rheumatol in Europe. 1997;26(1):4-5.
Review
For citations:
Mirahmedova Kh.T., Rustamova M.T., Khamraev Kh.H. Clinical and Functional State of the Intestine in Patients with Psoriatic Arthritis. Experimental and Clinical Gastroenterology. 2026;(2):17-22. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-246-2-17-22
Views:
64
JATS XML
Email this article 
